The heart failure spectrum: Time for a phenotype-oriented approach

Circulation

Volumn 119, Issue 24, 2009, Pages 3044-3046

  De Keulenaer, Gilles W ^a,b   Brutsaert, Dirk L ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Bldg T ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; PHENOTYPE; PRIORITY JOURNAL; SYSTOLE;

AGE OF ONSET; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; COHORT STUDIES; FEMALE; HEART FAILURE; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); PROGNOSIS; RISK FACTORS; SEX FACTORS; STROKE VOLUME; SURVIVAL RATE; TIME FACTORS; UNITED STATES; VENTRICULAR FUNCTION, LEFT;

EID: 67649563195     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.870006     Document Type: Editorial

References (12)

1. Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, Tu JV, Levy D. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham Heart Study of the National Heart, Lung, and Blood Institute. Circulation. 2009;119:3070-3077.
2. Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA. Candesartan in Heart Failure Reduction in Mortality (CHARM) investigators: influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005;112:3738 -3744.
3. Yip G, Wang M, Zhang Y, Fung JW, Ho PY, Sanderson JE. Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? Heart. 2002;87:121-125.
4. van Heerebeek L, Borbely A, Niessen HW, Bronzwaer JG, van der Velden J, Stienen GJ, Linke WA, Laarman GJ, Paulus WJ. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation. 2006;113: 1966 -1973.
5. Klapholz M, Maurer M, Lowe AM, Messineo F, Meisner JS, Mitchell J, Kalman J, Phillips RA, Steingart R, Brown EJ Jr, Berkowitz R, Moskowitz R, Soni A, Mancini D, Bijou R, Sehhat K, Varshneya N, Kukin M, Katz SD, Sleeper LA, Le Jemtel TH. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol. 2004;43: 1432-1438.
6. CHARM Investigators and Committees, Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial. Lancet. 2003;362:777-781.
7. The MERIT-HF study group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001-2007.
8. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A, I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359:2456-2467.
9. Barasch E, Gottdiener JS, Aurigemma G, Kitzman DW, Han J, Kop WJ, Tracy RP. The association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study. Circ Heart Fail. May 14, 2009. DOI:10.1161/CIRCHEARTFAILURE.108.828343. Available at: http://circheartfailure. ahajournals.org/cgi/rapidpdf/CIRCHEARTFAILURE. 108.828343v1. Accessed May 31, 2009.
10. Brutsaert DL. Cardiac dysfunction in heart failure: the cardiologist's love affair with time. Prog Cardiovasc Dis. 2006;49:157-181.
11. De Keulenaer GW, Brutsaert DL. Systolic and diastolic heart failure: different phenotypes of the same disease? Eur J Heart Fail. 2007;9:136 -143.
12. Brutsaert DL. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev. 2003;83:59-115.